SCHEMBL14728700

SCHEMBL14728700

CC(C)(C#N)N1CCN(c2ccc(Nc3nc(N4CCCCCC4)nc4cn[nH]c(=O)c34)cn2)CC1

nearest known ligand 0.81

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
SYK P43405 17/20 0.81
JAK2 O60674 12/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14717246 0.89 SYK (1.00) SYKJAK2
SCHEMBL30605000 0.89 SYK (1.00) SYKJAK2
SCHEMBL20837975 0.88 SYK (0.89) SYKJAK2
SCHEMBL30604972 0.86 SYK (1.00) SYKJAK2
SCHEMBL14716873 0.86 SYK (1.00) SYKJAK2
SCHEMBL30604983 0.85 SYK (0.83) SYKJAK2
SCHEMBL14717144 0.85 SYK (0.83) SYKJAK2
SCHEMBL14716673 0.85 SYK (0.77) SYKJAK2
SCHEMBL30604837 0.85 SYK (0.77) SYKJAK2
SCHEMBL14717634 0.84 SYK (1.00) SYKJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130053346-A1 PYRIMIDO-PYRIDAZINONE COMPOUNDS AND METHODS OF USE THEREOF ENDO PHARMACEUTICALS INC (US) 2013-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130053346-A1 PYRIMIDO-PYRIDAZINONE COMPOUNDS AND METHODS OF USE THEREOF THPO, TYMP, TYMS SYK 741/4885JAK2 139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.